selenocysteine has been researched along with Ovarian Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arnér, ES; Cheng, Q; Dunås, F; Grafström, J; Johansson, K; Lu, L; Martinsson Ahlzén, HS; Olofsson, MH; Samén, E; Ståhl, S; Stone-Elander, S; Thorell, JO; Wållberg, H | 1 |
Baek, WK; Cha, SD; Cho, CH; Cho, JW; Kim, SP; Kwon, TK; Park, JW; Suh, MH; Suh, SI; Yeo, JK | 1 |
2 other study(ies) available for selenocysteine and Ovarian Neoplasms
Article | Year |
---|---|
HER2-positive tumors imaged within 1 hour using a site-specifically 11C-labeled Sel-tagged affibody molecule.
Topics: Animals; Carbon Radioisotopes; Carcinoma, Squamous Cell; Cell Line, Tumor; Female; Gallium Radioisotopes; Gene Expression Regulation, Neoplastic; Humans; Isotope Labeling; Mice; Models, Molecular; Ovarian Neoplasms; Positron-Emission Tomography; Protein Conformation; Receptor, ErbB-2; Recombinant Fusion Proteins; Selenocysteine; Time Factors | 2012 |
Se-methylselenocysteine induces apoptosis through caspase activation and Bax cleavage mediated by calpain in SKOV-3 ovarian cancer cells.
Topics: Anticarcinogenic Agents; Apoptosis; bcl-2-Associated X Protein; Calpain; Caspases; Cysteine; Cytochrome c Group; Enzyme Activation; Female; Humans; Inhibitor of Apoptosis Proteins; Organoselenium Compounds; Ovarian Neoplasms; Poly(ADP-ribose) Polymerases; Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Selenocysteine; Tumor Cells, Cultured | 2002 |